Accession Number: | 0001209191-20-034877 |
Date: | 2020-06-03 |
Issuer: | ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) |
Original Submission Date: |
BENZENO SHARON
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
SUITE 200
SEATTLE, WA 98102
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-03 | M | 2,604 | a | $6.55 | 2,604 | direct | ||
COMMON STOCK | 2020-06-03 | M | 2,604 | a | $6.55 | 5,208 | direct | ||
COMMON STOCK | 2020-06-03 | M | 1,562 | a | $7.27 | 6,770 | direct | ||
COMMON STOCK | 2020-06-03 | S | 6,770 | d | $40.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.55 | 2020-06-03 | deemed execution date | M | 2,604 (d) | 2028-02-07 | common stock 2,604 | $6.55 | 43,271 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 6.55 | 2020-06-03 | deemed execution date | M | 2,604 (d) | 2028-10-01 | common stock 2,604 | $6.55 | 72,917 | direct | ||
COMMON STOCK (RIGHT TO BUY) | 7.27 | 2020-06-03 | deemed execution date | M | 1,562 (d) | 2029-02-07 | common stock 1,562 | $7.27 | 48,438 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 16, 2020. |
f2 | the options vested with respect to 1/4 of such shares on november 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |
f3 | the options vested with respect to 1/4 of such shares on october 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |
f4 | the options vested with respect to 1/4 of such shares on january 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |